AMP-224 drug page Clinical trials

Trials with AMP-224

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
17Planned patients

Showing 1–1 of 1

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer
Finished Phase 1 17 patients NCT02298946

Background: \- T-cells are white blood cells that can find and kill germs and tumors. Cancer can keep T-cells from working. Researchers think a new drug called AMP-224 might help the T-cells in people with cancer. They think the drug migh…

United States Nov 2014 – Mar 2017 Interventional
Combined with: Cyclophosphamide